CARL (Carlsmed, Inc. Common Stock) Stock Analysis - Financials
Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of May 21, 2026, CARL trades at $11.77 with a market cap of $297.13M and a P/E ratio of -5.59. CARL moved +4.07% today. Year to date, CARL is -2.65%; over the trailing twelve months it is flat. Its 52-week range spans $8.50 to $17.19. Analyst consensus is strong buy with an average price target of $18.40. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are CARL's key financials?
CARL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CARL recently traded at $11.77. Market cap is $297.13M. P/E ratio is -5.59. Revenue is $50.51M.
CARL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CARL recently traded at $11.77. Market cap is $297.13M. P/E ratio is -5.59. Revenue is $50.51M.
Is CARL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CARL. It does not provide personalized investment advice.